Advertisement
Advertisement
NBTX
Nanobiotix S.A. - ADR
34.35
USDSponsored
-2.25
-6.15%
Jun 24, 16:00 UTC -4
Closed
After-Market
34.05
-0.30
-0.86%
NBTX Earnings Reports
Positive Surprise Ratio
NBTX beat 4 of 16 last estimates.
25%
Next Report
Date of Next Report
Sep 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$30.50M
/$0.54
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+14.49%
/-590.91%
Nanobiotix S.A. - ADR earnings per share and revenue
On May 19, 2026, NBTX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of 0.54 USD, with revenue projected to reach 30.50 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Nanobiotix S.A. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Nanobiotix S.A. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Nanobiotix S.A. - ADR's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Nanobiotix S.A. - ADR expected to report next?
The next earning report is scheduled for Sep 28, 2026.
What are the forecasts for Nanobiotix S.A. - ADR's next earnings report?
Based on 3
analysts, Nanobiotix S.A. - ADR is expected to report EPS of $0.54 and revenue of $30.50M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement